Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Denisov

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Voprosy Onkologii|January 1, 1987
[Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines]N I Perevodchikova, L E Denisov, N F Orel, et al.
Khirurgiia|July 29, 1998
[The results of treating stomach cancer at a medical center]N N Malinovskiĭ, L E Denisov, A P Nikolaev, et al.
Voprosy Onkologii|January 1, 1991
[The clinical significance of determining the HLA-DR4 antigen in patients with breast cancer]L M Iarygin, V S Malyshev, I S Polianskaia, et al.
Oncology|May 1, 1995
A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamideK Kolaric, V Bradamante, J Cervek, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Voprosy Onkologii|January 1, 1987
[Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines]N I Perevodchikova, L E Denisov, N F Orel, et al.
Khirurgiia|July 29, 1998
[The results of treating stomach cancer at a medical center]N N Malinovskiĭ, L E Denisov, A P Nikolaev, et al.
Voprosy Onkologii|January 1, 1991
[The clinical significance of determining the HLA-DR4 antigen in patients with breast cancer]L M Iarygin, V S Malyshev, I S Polianskaia, et al.
Oncology|May 1, 1995
A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamideK Kolaric, V Bradamante, J Cervek, et al.
Pageof 3